SynthesisClinical psychology review2018
A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?
Synthesis in Clinical psychology review, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.
- Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.Schizophrenia research · 2019Pooled it
- Uncontrolled trial of specialized, multi-component care for individuals with first-episode psychosis: Effects on motivation orientations.Early intervention in psychiatry · 2021Trial
- Mobile enhancement of motivation in schizophrenia: A pilot randomized controlled trial of a personalized text message intervention for motivation deficits.Journal of consulting and clinical psychology · 2020Trial
- Computational phenotypes underlying effort-based decision-making and negative symptoms in a transdiagnostic severe mental illness sample.Molecular psychiatry · 2026Article
- Global reward processing deficits predict negative symptoms transdiagnostically and transphasically in a severe mental illness-spectrum sample.European archives of psychiatry and clinical neuroscience · 2024Article
- Bridge centrality network structure of negative symptoms in people with schizophrenia.European archives of psychiatry and clinical neuroscience · 2023Article
- Validity and reliability of a Chinese version of the self-evaluation of negative symptoms.Brain and behavior · 2023Article
- Are effort-based decision-making tasks worth the effort?-A study on the associations between effort-based decision-making tasks and self-report measures.International journal of methods in psychiatric research · 2023Article
- The effect of salience of rewards on effort-based decision making in psychotic disorders.BMC psychiatry · 2022Article
- Impaired Effort Allocation in Patients with Recent-Onset Schizophrenia and Its Relevance to Negative Symptoms Assessments and Persistent Negative Symptoms.Journal of clinical medicine · 2022Article
- Self-Report Measures of Anhedonia and Approach Motivation Weakly Correspond to Anhedonia and Depression Assessed via Clinical Interviews.Personality and individual differences · 2021Article
- Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development.NPJ schizophrenia · 2021Review
- Digital phenotyping of negative symptoms: the relationship to clinician ratings.Schizophrenia bulletin · 2021Article
- Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis.Brain sciences · 2020Article
- Metacognition moderates the relationship between self-reported and clinician-rated motivation in schizophrenia.Schizophrenia research. Cognition · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
An array of self-reported, clinician-rated, and performance-based measures has been used to assess motivation in schizophrenia; however, the convergent validity evidence for these motivation assessment methods is mixed. The current study is a series of meta-analyses that summarize the relationships between methods of motivation measurement in 45 studies of people with schizophrenia. The overall mean effect size between self-reported and clinician-rated motivation measures (r = 0.27, k = 33) was significant, positive, and approaching medium in magnitude, and the overall effect size between performance-based and clinician-rated motivation measures (r = 0.21, k = 11) was positive, significant, and small in magnitude. The overall mean effect size between self-reported and performance-based motivation measures was negligible and non-significant (r = -0.001, k = 2), but this meta-analysis was underpowered. Findings suggest modest convergent validity between clinician-rated and both self-reported and performance-based motivation measures, but additional work is needed to clarify the convergent validity between self-reported and performance-based measures. Further, there is likely more variability than similarity in the underlying construct that is being assessed across the three methods, particularly between the performance-based and other motivation measurement types. These motivation assessment methods should not be used interchangeably, and measures should be more precisely described as the specific motivational construct or domain they are capturing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.